Atlas Trials

Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease

Clinical trial NCT02947022 · TERMINATED

Trial details

NCT number
NCT02947022
Sponsor
University of North Carolina, Chapel Hill
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
HeadacheCognitive DisturbanceSkin HyperpigmentationArthralgia
Start date
2016-10-01
Primary completion
2017-01-31
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.